Nanomedicines for Improved Management of Ectopic Pregnancy: A Narrative Review.
Small.
2023 Jul 20;:e2301873. doi: 10.1002/smll.202301873. [Epub ahead of print] Review. PubMed PMID:
37471169; PubMed Central PMCID:
PMC10837845.
Glutathione-Responsive Methotrexate Polymersomes for Potential Management of Ectopic Pregnancy.
Small.
2023 Jul 14;:e2302969. doi: 10.1002/smll.202302969. [Epub ahead of print] PubMed PMID:
37452511; PubMed Central PMCID:
PMC10787806.
A Photoacoustic Contrast Nanoagent with a Distinct Spectral Signature for Ovarian Cancer Management.
Adv Healthc Mater.
2023 Apr;12(9):e2202946. doi: 10.1002/adhm.202202946. Epub 2022 Dec 21. PubMed PMID:
36495088; PubMed Central PMCID:
PMC10079555.
Novel Nanoparticle-Based Treatment and Imaging Modalities.
Pharmaceutics.
2023 Jan 11;15(1). doi: 10.3390/pharmaceutics15010244. PubMed PMID:
36678873; PubMed Central PMCID:
PMC9861272.
Nano-Theranostic Modality for Visualization of the Placenta and Photo-Hyperthermia for Potential Management of Ectopic Pregnancy.
Small.
2023 Jan;19(2):e2202343. doi: 10.1002/smll.202202343. Epub 2022 Nov 17. PubMed PMID:
36394151; PubMed Central PMCID:
PMC9839489.
Targeting Estrogen Receptor-Positive Breast Microtumors with Endoxifen-Conjugated, Hypoxia-Sensitive Polymersomes.
ACS Omega.
2021 Oct 26;6(42):27654-27667. doi: 10.1021/acsomega.1c02250. eCollection 2021 Oct 26. PubMed PMID:
34722965; PubMed Central PMCID:
PMC8552235.
A targeted combinatorial therapy for Ewing's sarcoma.
Nanomedicine.
2021 Oct;37:102446. doi: 10.1016/j.nano.2021.102446. Epub 2021 Jul 23. PubMed PMID:
34303840; PubMed Central PMCID:
PMC8464505.
Discovery and Validation of a Compound to Target Ewing's Sarcoma.
Pharmaceutics.
2021 Sep 24;13(10). doi: 10.3390/pharmaceutics13101553. PubMed PMID:
34683845; PubMed Central PMCID:
PMC8538197.
Near-Infrared Heptamethine Cyanine Dyes for Nanoparticle-Based Photoacoustic Imaging and Photothermal Therapy.
J Med Chem.
2021 Jun 24;64(12):8798-8805. doi: 10.1021/acs.jmedchem.1c00771. Epub 2021 Jun 3. PubMed PMID:
34081463; PubMed Central PMCID:
PMC10807376.
Nanomedicines for Endometriosis: Lessons Learned from Cancer Research.
Small.
2021 Feb;17(7):e2004975. doi: 10.1002/smll.202004975. Epub 2021 Jan 25. Review. PubMed PMID:
33491876; PubMed Central PMCID:
PMC7928207.
Systemically Delivered Magnetic Hyperthermia for Prostate Cancer Treatment.
Pharmaceutics.
2020 Oct 25;12(11). doi: 10.3390/pharmaceutics12111020. PubMed PMID:
33113767; PubMed Central PMCID:
PMC7692290.
Biodegradable Hypericin-Containing Nanoparticles for Necrosis Targeting and Fluorescence Imaging.
Mol Pharm.
2020 May 4;17(5):1538-1545. doi: 10.1021/acs.molpharmaceut.9b01238. Epub 2020 Apr 7. PubMed PMID:
32212709; PubMed Central PMCID:
PMC7341666.
Nanoparticle-Based Platform for Activatable Fluorescence Imaging and Photothermal Ablation of Endometriosis.
Small.
2020 May;16(18):e1906936. doi: 10.1002/smll.201906936. Epub 2020 Apr 6. PubMed PMID:
32250034; PubMed Central PMCID:
PMC7210057.
Transarterial Delivery of a Biodegradable Single-Agent Theranostic Nanoprobe for Liver Tumor Imaging and Combinatorial Phototherapy.
J Vasc Interv Radiol.
2019 Sep;30(9):1480-1486.e2. doi: 10.1016/j.jvir.2019.03.004. Epub 2019 Jun 13. PubMed PMID:
31202675; PubMed Central PMCID:
PMC7364663.
Biocompatible Nanoclusters with High Heating Efficiency for Systemically Delivered Magnetic Hyperthermia.
ACS Nano.
2019 Jun 25;13(6):6383-6395. doi: 10.1021/acsnano.8b06542. Epub 2019 May 17. PubMed PMID:
31082199; PubMed Central PMCID:
PMC6645784.
Applications of nanoparticles in biomedical imaging.
Nanoscale.
2019 Jan 17;11(3):799-819. doi: 10.1039/c8nr07769j. Review. PubMed PMID:
30603750; PubMed Central PMCID:
PMC8112886.
Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA.
Theranostics.
2018;8(19):5276-5288. doi: 10.7150/thno.27847. eCollection 2018. PubMed PMID:
30555546; PubMed Central PMCID:
PMC6276093.
Intraperitoneal nanotherapy for metastatic ovarian cancer based on siRNA-mediated suppression of DJ-1 protein combined with a low dose of cisplatin.
Nanomedicine.
2018 Jun;14(4):1395-1405. doi: 10.1016/j.nano.2018.03.005. Epub 2018 Apr 7. PubMed PMID:
29635082; PubMed Central PMCID:
PMC6174103.
A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy.
Theranostics.
2018;8(3):767-784. doi: 10.7150/thno.21209. eCollection 2018. PubMed PMID:
29344305; PubMed Central PMCID:
PMC5771092.
Phototheranostic nanoplatform based on a single cyanine dye for image-guided combinatorial phototherapy.
Nanomedicine.
2017 Apr;13(3):955-963. doi: 10.1016/j.nano.2016.11.005. Epub 2016 Nov 21. PubMed PMID:
27884637.
LHRH-Targeted Drug Delivery Systems for Cancer Therapy.
Mini Rev Med Chem.
2017;17(3):258-267. doi: 10.2174/1389557516666161013111155. Review. PubMed PMID:
27739358; PubMed Central PMCID:
PMC6645782.
Mechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian Cancer.
Mol Pharm.
2016 Jun 6;13(6):2070-83. doi: 10.1021/acs.molpharmaceut.6b00205. Epub 2016 May 26. PubMed PMID:
27170529; PubMed Central PMCID:
PMC5332073.
ROS-induced nanotherapeutic approach for ovarian cancer treatment based on the combinatorial effect of photodynamic therapy and DJ-1 gene suppression.
Nanomedicine.
2015 Nov;11(8):1961-70. doi: 10.1016/j.nano.2015.07.005. Epub 2015 Jul 31. PubMed PMID:
26238076.
Phthalocyanine-loaded graphene nanoplatform for imaging-guided combinatorial phototherapy.
Int J Nanomedicine.
2015;10:2347-62. doi: 10.2147/IJN.S81097. eCollection 2015. PubMed PMID:
25848255; PubMed Central PMCID:
PMC4378304.
Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy.
Nanoscale.
2015 Mar 7;7(9):3888-902. doi: 10.1039/c4nr06050d. PubMed PMID:
25422147.
Enantiopure Cryptophane-(129)Xe Nuclear Magnetic Resonance Biosensors Targeting Carbonic Anhydrase.
Supramol Chem.
2015 Jan 1;27(1-2):65-71. doi: 10.1080/10610278.2014.906601. PubMed PMID:
25506191; PubMed Central PMCID:
PMC4260966.
Temperature-tunable iron oxide nanoparticles for remote-controlled drug release.
AAPS PharmSciTech.
2014 Aug;15(4):963-72. doi: 10.1208/s12249-014-0131-x. Epub 2014 May 13. PubMed PMID:
24821220; PubMed Central PMCID:
PMC4113623.
Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells.
Int J Pharm.
2013 Dec 15;458(1):169-80. doi: 10.1016/j.ijpharm.2013.09.032. Epub 2013 Oct 1. PubMed PMID:
24091153.
Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug.
Clin Cancer Res.
2013 Nov 15;19(22):6193-204. doi: 10.1158/1078-0432.CCR-13-1536. Epub 2013 Sep 13. PubMed PMID:
24036854; PubMed Central PMCID:
PMC3846837.
A multifunctional theranostic platform based on phthalocyanine-loaded dendrimer for image-guided drug delivery and photodynamic therapy.
Mol Pharm.
2013 Oct 7;10(10):3946-58. doi: 10.1021/mp400397t. Epub 2013 Sep 10. PubMed PMID:
24020847.
Direct modulation of microtubule stability contributes to anthracene general anesthesia.
J Am Chem Soc.
2013 Apr 10;135(14):5389-98. doi: 10.1021/ja311171u. Epub 2013 Mar 29. PubMed PMID:
23484901; PubMed Central PMCID:
PMC3671381.
Synthesis of enantiopure, trisubstituted cryptophane-A derivatives.
Org Lett.
2012 Jul 20;14(14):3580-3. doi: 10.1021/ol300943w. Epub 2012 Jul 11. PubMed PMID:
22783828; PubMed Central PMCID:
PMC3484212.
Shorter synthesis of trifunctionalized cryptophane-A derivatives.
Org Lett.
2011 Mar 18;13(6):1414-7. doi: 10.1021/ol200088f. Epub 2011 Feb 18. PubMed PMID:
21332141; PubMed Central PMCID:
PMC3058506.
Multiple hindered rotators in a gyroscope-inspired tribenzylamine hemicryptophane.
J Org Chem.
2011 Mar 4;76(5):1418-24. doi: 10.1021/jo102480s. Epub 2011 Jan 27. PubMed PMID:
21271707; PubMed Central PMCID:
PMC3045655.
Crystallographic observation of 'induced fit' in a cryptophane host-guest model system.
Nat Commun.
2010;1:148. doi: 10.1038/ncomms1151. Epub 2010 Dec 21. PubMed PMID:
21266998; PubMed Central PMCID:
PMC3105606.
Functionalized 129Xe contrast agents for magnetic resonance imaging.
Curr Opin Chem Biol.
2010 Feb;14(1):97-104. doi: 10.1016/j.cbpa.2009.10.009. Epub 2009 Nov 13. Review. PubMed PMID:
19914122; PubMed Central PMCID:
PMC2819603.
Stepwise functionalization of ZnO nanotips with DNA.
Langmuir.
2009 Feb 17;25(4):2107-13. doi: 10.1021/la8026946. PubMed PMID:
19199718.
Pyrene-terminated phenylenethynylene rigid linkers anchored to metal oxide nanoparticles.
J Phys Chem B.
2006 Aug 17;110(32):15734-41. doi: 10.1021/jp0623847. PubMed PMID:
16898719.
Binding studies of molecular linkers to ZnO and MgZnO nanotip films.
J Phys Chem B.
2006 Apr 6;110(13):6506-15. doi: 10.1021/jp0570317. PubMed PMID:
16570948.
What would you like to do?